Moneycontrol
Get App
Last Updated : Jul 18, 2018 03:04 PM IST | Source: Moneycontrol.com

HCG Q1 PAT may dip 85.8% YoY to Rs. 7 cr: Kotak

Net Sales are expected to increase by 20.5 percent Y-o-Y (up 3.6 percent Q-o-Q) to Rs. 230.3 crore, according to Kotak.

Moneycontrol News @moneycontrolcom
Merck | Year to date change : 94% (Image: Reuters)
Merck | Year to date change : 94% (Image: Reuters)
 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Kotak has come out with its first quarter (April-June’ 18) earnings estimates for the Pharmaceuticals sector. The brokerage house expects HCG to report net profit at Rs. 7 crore down 85.8% year-on-year (down 74.1% quarter-on-quarter).


Net Sales are expected to increase by 20.5 percent Y-o-Y (up 3.6 percent Q-o-Q) to Rs. 230.3 crore, according to Kotak.


Earnings before interest, tax, depreciation and amortisation (EBITDA) are likely to rise by 11.9 percent Y-o-Y (up 2.5 percent Q-o-Q) to Rs. 33 crore.


Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.



Subscribe to Moneycontrol Pro and gain access to curated markets data, exclusive trading recommendations, independent equity analysis, actionable investment ideas, nuanced takes on macro, corporate and policy actions, practical insights from market gurus and much more.
First Published on Jul 18, 2018 03:04 pm
Loading...
Sections
Follow us on
Available On
PCI DSS Compliant